SPHERA FUNDS MANAGEMENT LTD.
CIK 0001496201 · TEL AVIV, L3 · Quarter end: 2026-06-30 · Filed on: 2026-08-14 · Open the SEC source ↗
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$766.5M
2026 Q2
Positions
105
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
34.5%
Est. Net Flow (Q)
—
2026 Q2
Top Holdings
TEVA
TEVA PHARMACEUTICAL INDS LTD
6.6%
MLYS
MINERALYS THERAPEUTICS INC
5.2%
TSEM
TOWER SEMICONDUCTOR LTD
3.7%
XBIPUT
SPDR SERIES TRUST
3.1%
SNDX
SYNDAX PHARMACEUTICALS INC
2.9%
BIIBCALL
BIOGEN INC
2.8%
BIIB
BIOGEN INC
2.7%
RARE
ULTRAGENYX PHARMACEUTICAL IN
2.6%
New / Increased
No prior quarter data
Reduced / Exited
No prior quarter data
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.